Investing.com – Hologic (NASDAQ: ) reported third quarter EPS of $1.06, $0.04 better than the analyst estimate of $1.02. Revenue for the quarter came in at $1.01B versus the consensus estimate of $1B.

Guidance

Hologic sees FY 2024 EPS of $4.04-$4.11 versus the analyst consensus of $4.07.

Hologic sees FY 2024 revenue of $4.02B-$4.07B versus the analyst consensus of $4.03B.

Hologic’s stock price closed at $79.64. It is up 4.91% in the last 3 months and down -1.30% in the last 12 months.

Hologic saw 4 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See Hologic’s stock price’s past reactions to earnings here.

According to InvestingPro, Hologic’s Financial Health score is “good performance“.

Check out Hologic’s , and Hologic’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar